BALA CYNWYD, Pa., Oct. 30, 2015 /PRNewswire/ -- Law office of
Brodsky & Smith, LLC announces that it is investigating
potential claims against the Board of Directors of TriVascular
Technologies, Inc. ("TriVascular" or "the Company") (Nasdaq-
TRIV-News) for possible breaches of fiduciary duty and other
violations of state law in connection with the sale of the Company
to Endologix, Inc. ("Endologix").
Click here to learn more about the investigation
http://brodsky-smith.com/994-triv-trivascular-technologies-inc.html,
or call: 877-534-2590. There is no cost or obligation to you.
Under the terms of the transaction TriVascular shareholders will
receive only a combination of cash and stock valued at $9.10 for each share of TriVascular stock they
own. The investigation concerns whether the Board of TriVascular
breached their fiduciary duties to shareholders and whether
Endologix is underpaying for TriVascular. The transaction may
undervalue TriVascular and will result in a loss for many
TriVascular shareholders. For example, TriVascular stock traded at
$17.54 per share on June 24, 2014 and an analyst has placed a
$13.00 per share price target on
TriVascular stock.
If you own shares of TriVascular stock and wish to discuss the
legal ramifications of the investigation, or have any
questions, you may e-mail or call the law office of Brodsky &
Smith, LLC who will, without obligation or cost to you, attempt to
answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith,
LLC, Two Bala Plaza, Suite 510, Bala
Cynwyd, PA 19004, by visiting
http://brodsky-smith.com/994-triv-trivascular-technologies-inc.html,
or calling toll free 877-LEGAL-90.
Brodsky & Smith, LLC is a litigation law firm with extensive
expertise representing shareholders throughout the nation in
securities and class action lawsuits. The attorneys at Brodsky
& Smith have been appointed by numerous courts throughout the
country to serve as lead counsel in class actions and have
successfully recovered millions of dollars for our clients and
shareholders. Attorney advertising. Prior results do not guarantee
a similar outcome.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/shareholder-alert-brodsky--smith-llc-announces-investigation-of-the-board-of-directors-of-trivascular-technologies-inc--triv-300169732.html
SOURCE Brodsky & Smith, LLC